SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-15-010025
Filing Date
2015-11-09
Accepted
2015-11-09 07:00:53
Documents
12
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q akba-10q_20150930.htm 10-Q 1739229
2 EX-31.1 akba-ex31_7.htm EX-31 16811
3 EX-31.2 akba-ex31_9.htm EX-31 16643
4 EX-32.1 akba-ex32_8.htm EX-32 13292
5 EX-99.1 akba-ex99_12.htm EX-99 141572
6 GRAPHIC g201511061242507631755.jpg GRAPHIC 2066
  Complete submission text file 0001564590-15-010025.txt   6908715

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT akba-20150930.xml EX-101.INS 1672605
8 XBRL TAXONOMY EXTENSION SCHEMA akba-20150930.xsd EX-101.SCH 36594
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE akba-20150930_cal.xml EX-101.CAL 44794
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE akba-20150930_def.xml EX-101.DEF 105961
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE akba-20150930_lab.xml EX-101.LAB 294980
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE akba-20150930_pre.xml EX-101.PRE 235411
Mailing Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1100 CAMBRIDGE MA 02142 617-871-2098
Akebia Therapeutics, Inc. (Filer) CIK: 0001517022 (see all company filings)

IRS No.: 208756903 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36352 | Film No.: 151213932
SIC: 2834 Pharmaceutical Preparations